Merck & Co Inc. said on Tuesday that the U.S. Food and Drug Administration approved its immunotherapy Keytruda as a treatment for an early form of tough-to-treat breast cancer in combination with chemotherapy. The FDA approval is for treating triple-negative breast cancer (TNBC), an aggressive form of the disease with an increased risk of recurrence….
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
July 28, 2021
admin
Breast cancerBusinesschemotherapyCompaniesFood and Drug AdministrationInternationalMerck & CoUSUS NewsWorld
0 Comment
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Merck & Co said on Wednesday it would supply about 60,000–100,000 doses of its experimental COVID-19 treatment to the U.S. government for up to about $356 million. The agreement will help support advanced development and large-scale manufacturing of the company’s investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19, the U.S. Department…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`